Latest 8-K filings

Baker Hughes Company presented updated fiscal-year 2026 financial guidance, incorporating the recent acquisition of Chart Industries, Inc., at the Barclays 2026 CEO Energy-Power Conference.

Sound Point Meridian Capital, Inc. reported an unaudited estimate for its common stock net asset value per share as of August 31, 2026, falling between $9.52 and $9.62.

Vivos Therapeutics, Inc. amends a prior filing to correct the report date and disclose the issuance of over 11 million shares to Streeterville Capital, LLC, significantly diluting existing shareholders.

Ellington Credit Company announced a monthly common distribution of $0.08 per share, payable on October 30, 2026.

Chime Financial announces a definitive agreement to acquire Stride Bank, N.A. for $590 million, aiming to integrate its banking infrastructure and enhance its vertically integrated platform.

Ellington Financial Inc. announced its Board of Directors has declared monthly and quarterly dividends for its common and preferred stockholders, with payment dates in late October and September 2026.

Murphy Oil Corporation presented its latest operational and financial updates, highlighting key exploration discoveries and a refined capital allocation strategy.

Ocugen announces the first patient dosed in its global Phase 3 trial for OCU410, a gene therapy candidate for Geographic Atrophy, following FDA alignment on trial design and RMAT designation.

Repligen Corporation announces the expiration of the Hart-Scott-Rodino Waiting Period for its acquisition of BioLife Solutions, Inc., moving closer to deal completion.

Nerdy Inc. announced the resignation of its Chief Accounting Officer, Kyle Callaway, effective September 1, 2026, with the CFO assuming interim responsibilities.

Estrella Immunopharma received a notice from Nasdaq for failing to meet the minimum market value of listed securities requirement, with a 180-day period to regain compliance.

Hepion Pharmaceuticals, Inc. has issued a $500,000 senior secured convertible promissory note to Gravitas Capital LP, with a maturity date of September 3, 2027, and includes a warrant for common stock purchase.

StimCell Energetics Inc. has entered into an advisory services agreement with Stonegate Capital Markets, Inc. to identify prospective investors and strategic counterparties for potential transactions.

Worthington Steel, Inc. has signed a Domination and Profit and Loss Transfer Agreement (DPLTA) with its subsidiary Worthington Steel GmbH and Kloeckner & Co SE, a key step towards full integration.

Constellation Brands has announced the redemption of all outstanding $600 million in 4.350% Senior Notes due 2027, with the redemption date set for September 18, 2026.

Freeport-McMoRan's subsidiary, PT Freeport Indonesia, has amended and restated its senior unsecured revolving credit facility, extending the maturity date to September 2031.

Perspective Therapeutics, Inc. has updated its corporate presentation, detailing progress across three independent clinical-stage radiopharmaceutical programs targeting oncology.

SUNation Energy and Suniva have amended their merger agreement, adjusting key financial conditions, warrant treatment, and stockholder approval requirements.

United Therapeutics announces an accelerated share repurchase agreement to buy back approximately $477.6 million of its common stock, signaling strong confidence in future growth.

Suniva announced the completion of an $835 million capital raise to fund a new 4.5 GW solar cell manufacturing facility in South Carolina, significantly expanding its U.S. production capacity.

AtaiBeckley Inc. announced the overwhelming approval of its merger with Eli Lilly and Company by its shareholders, paving the way for a September 11, 2026, closing.

Curaleaf Holdings, Inc. released a fact sheet to counter what it describes as misleading statements from Aurora Cannabis regarding Curaleaf's acquisition proposal.

Bio-Key International has adjourned its 2026 Annual Meeting of Stockholders to allow more time for shareholders to vote on a proposal related to warrant issuance.

Cactus, Inc. presented its September 2026 investor materials, showcasing strong financial performance, strategic growth initiatives, and a positive outlook for its Pressure Control and Spoolable Technologies segments.

Tenet Healthcare Corporation announced the pricing of a $2.0 billion senior notes offering due 2034, upsized from $1.5 billion, to refinance existing debt.

Babcock & Wilcox Enterprises, Inc. announced its board of directors has approved a dividend payment for its outstanding 7.75% Series A Cumulative Perpetual Preferred Stock.

MNTN, Inc. has appointed Michael J. Katz, a seasoned executive with extensive experience in telecommunications and marketing, to its Board of Directors.

Stablecoin Development Corporation has filed a Certificate of Withdrawal for multiple series of its preferred stock, returning them to authorized but unissued status.

Amylyx Pharmaceuticals has entered into agreements with Bachem Americas and Polypeptide Group AG to secure long-term manufacturing and supply of its avexitide drug substance.

Payoneer Global Inc. files an 8-K detailing supplemental merger disclosures and addressing two shareholder lawsuits related to the proposed acquisition by Nuvei.